IN SILICO INVESTIGATION AND DOCKING STUDIES OF E2F3 TUMOR MARKER: DISCOVERY AND EVALUATION OF POTENTIAL INHIBITORS FOR PROSTATE AND BREAST CANCER. Int. J. Pharm. Sci. Drug Res. [Internet]. 2010 Oct. 1 [cited 2025 Oct. 17];2(4):254-60. Available from: https://ijpsdronline.com/index.php/journal/article/view/137